Balaji Amines has the potential to undergo a rerating, says Ashish Chugh, Investment Analyst & Author of Hidden Gems.
Chugh told CNBC-TV18, "Balaji Amines is a Maharashtra based company. This company manufactures various kinds of amines and derivatives of specialty chemicals and natural products. This company has got three manufacturing plants; two are located close to Solapur and one plant located in Hyderabad. This company caters to a wide range of industries starting from pharmaceutical to agrochemicals. It also caters to the chemical industry and FMCG in a small way. Almost all pharmaceutical companies whether Indian or international, the major international companies, are the customers of Balaji Amines."
He further added, "If you take a look at the financials of the company, for FY10 company achieved a sales of about Rs 260 crore which was up by close to 4% compared to FY09 and profit after tax was up by about 35% to about Rs 20 crore. This company has got a small equity of about 6.5 crore. In the first half of the current financial year, sales are up by close to 35% to about Rs 170 crore. Profit after tax is up by 30% to about Rs 16 crore. Earnings per share (EPS) on an annualised basis is coming close to Rs 10, the stock is traded at about Rs 40, which means that the P/E in this case is about 4. Even assuming a conservative P/E of 8, in case they don
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.